Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Collegium Pharmaceutical, Inc. Collegium Announces $35 Million Accelerated Share Repurchase Program May 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports First Quarter 2024 Financial Results May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces CEO Transition May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER April 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 April 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026 April 11, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference April 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results February 22, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 February 08, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Provides 2024 Financial Guidance January 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent November 27, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces $25 Million Accelerated Share Repurchase Program November 09, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Participate in Upcoming Investor Conferences November 08, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports Third Quarter 2023 Financial Results November 07, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023 August 28, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026 August 24, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces $50 Million Accelerated Share Repurchase Program August 07, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year August 03, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023 July 20, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Participate in Jefferies Healthcare Conference June 01, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports First Quarter 2023 Financial Results May 04, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Report First Quarter 2023 Financial Results on May 4, 2023 April 20, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference April 11, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results February 23, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report February 22, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering February 07, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering February 06, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results February 06, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Collegium Provides 2023 Financial Guidance January 04, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Tickers COLL Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.